Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1321MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02
B.T. Li, David Planchard, Kōichi Goto, Egbert Frederik Smit, J. De Langen, Yasushi Goto and 14 more
- Rank
- 86 of 3,639
- Percentile
- top 2.4%
- Where
- Annals of Oncology, 2023
- Citations
- 39
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.